$6.890
+0.143 (+2.07%)收盘时
TVGN 同业对比
In the context of the broader market, TVGN competes directly with industry leaders such as FLNA and BCTX. With a market capitalization of $43.95M, it holds a significant position in the sector. When comparing efficiency, TVGN's gross margin of N/A stands against FLNA's N/A and BCTX's N/A. Such benchmarking helps identify whether Tevogen Inc is trading at a premium or discount relative to its financial performance.
Tevogen Bio Holdings Inc 财务表现
Tevogen has consistently reported negative net income, with the latest quarter showing a loss of -5,839,776 USD. The company has a current ratio of 0.33, indicating liquidity issues, and total equity remains negative at -8,888,760 USD.
Financials
FY2026Q2
YoY:
+4.00%
-5.66M
Operating Profit
FY2026Q1
YoY:
-47.47%
-5.45M
Net Income after Tax
FY2026Q2
YoY:
-0.65%
-1.52
EPS - Diluted
FY2025Q4
-2.25M
Free Cash Flow
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。